EverSource Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Buy |
66
+55
| +500% | +$13.3K | ﹤0.01% | 2464 |
|
|
2025
Q1 | $2.68K | Sell |
11
-32
| -74% | -$7.79K | ﹤0.01% | 2791 |
|
|
2024
Q4 | $14.1K | Buy |
43
+10
| +30% | +$3.29K | ﹤0.01% | 1822 |
|
|
2024
Q3 | $11K | Buy |
33
+7
| +27% | +$2.34K | ﹤0.01% | 1808 |
|
|
2024
Q2 | $8.8K | Buy |
26
+4
| +18% | +$1.35K | ﹤0.01% | 1920 |
|
|
2024
Q1 | $5.94K | Buy |
22
+3
| +16% | +$809 | ﹤0.01% | 1964 |
|
|
2023
Q4 | $6.14K | Sell |
19
-9
| -32% | -$2.91K | ﹤0.01% | 1774 |
|
|
2023
Q3 | $10K | Sell |
28
-12
| -30% | -$4.3K | ﹤0.01% | 1422 |
|
|
2023
Q2 | $15.2K | Buy |
40
+13
| +48% | +$4.93K | ﹤0.01% | 1259 |
|
|
2023
Q1 | $12.9K | Buy |
27
+15
| +125% | +$7.19K | ﹤0.01% | 1261 |
|
|
2022
Q4 | $5.05K | Buy |
12
+8
| +200% | +$3.36K | ﹤0.01% | 1593 |
|
|
2022
Q3 | $2K | Sell |
4
-2
| -33% | -$1K | ﹤0.01% | 1631 |
|
|
2022
Q2 | $3K | Buy |
6
+3
| +100% | +$1.5K | ﹤0.01% | 1380 |
|
|
2022
Q1 | $2K | Sell |
3
-11
| -79% | -$7.33K | ﹤0.01% | 1494 |
|
|
2021
Q4 | $11K | Buy |
+14
| New | +$11K | ﹤0.01% | 916 |
|